Two populations of endothelial cell antibodies cross-react with heparin

Lupus

Volumn 7, Issue 2, 1998, Pages 86-94

  Renaudineau, Y ^a   Revelen, R ^a   Bordron, A ^a   Mottier, D ^a   Youinou, P ^a   Le Corre, R ^a  

^a UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

Author keywords

Antibodies; Endothelial cells; Heparin

Indexed keywords

CELL ANTIBODY; CROSS REACTING ANTIBODY; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN; PROTEIN G; SEPHAROSE; SODIUM CHLORIDE;

ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THROMBOSIS;

ANTIBODY SPECIFICITY; AUTOANTIBODIES; BINDING, COMPETITIVE; BIOLOGICAL MARKERS; CROSS REACTIONS; ENDOTHELIUM, VASCULAR; HEPARIN; HUMANS; IMMUNOGLOBULIN G;

EID: 0031932988     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120398678919769     Document Type: Article

References (38)

1. Meroni PL, Youinou P. Endothelial cell antibodies. In: Autoantibodies. Peter JB, Shoenfeld Y (eds). Elsevier: Amsterdam, 1996; pp 245-252.
2. Youinou P, Meroni PL, Khamashta MA, Shoenfeld Y A need for standardization of the antiendothelial cell antibody test. Immunol Today 1995; 16: 363-364.
3. Salojin KV et al. Antiendothelial cell antibodies: useful markers of systemic sclerosis. Am J Med 1997; 102: 178-185.
4. Del Papa N et al. Characterization of the anti-endothelial antibodies in primary and secondary autoimmune vasculitis. Clin Immunol Immunopathol 1997; 70: 211-216
5. Meroni PL. What is going to happen tomorrow in the field of antiendothelial cell autoantibodies related to vasculitis? Ann Méd Int (Paris) 1994; 145: 467-468.
6. Kjellen L, Lindahl U. Proteoglycans: structure and interactions. Annu Rev Biochem 1991; 60: 443-475.
7. Fillit H, Lahita R. Antibodies to vascular heparan sulfate proteoglycan in patients with systemic lupus erythematosus Autoimmunity 1991; 9: 159-164.
8. Fillit H, Edstrom W, Yang CP, Moran T, Dimitriu-Bona A. Autoimmune MRL mice express high-affinity IgG2b monoclonal autoantibodies to heparin. Clin Immunol Immunopathol 1996; 81: 62-67.
9. Chan TM, Yu PM, Tsang KLC, Cheng IKP. Endothelial cell binding by human polyclonal anti-DNA antibodies: relationship to disease activity and endothelial functional alterations. Clin Exp Immunol 1995; 100: 506-513.
10. Direskeneli H, D'Cruz D, Khamashta MA, Hughes GRV. Autoantibodies against endothelial cells, extracellular matrix, and human collagen type IV in patients with systemic vasculitis. Clin Immunol Immunopathol 1994; 70: 206-210.
11. Shibata S, Harpel PC, Gharavi A, Rand J, Fillit H. Autoantibodies to heparin from patients with antiphospholipid antibody syndrome inhibit formation of antithrombin III-thrombin complexes. Blood 1994; 83: 2532-2540
12. Tan EM et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
13. Hughes GRV. The antiphospholipid syndrome : ten years on. Lancet 1993; ii: 341-344.
14. Vitali C Diagnostic criteria for Sjögren's syndrome : results of a European multicenter prospective study. Arthritis Rheum 1993; 36: 340-347
15. Masi AT et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-590.
16. Hunder GG et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990; 33: 1122-1128.
17. Lightfoot RW Jr, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990; 33: 1088-1093.
18. Leavitt RY et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis Arthritis Rheum 1990; 33: 1101-1107.
19. Edgell CJS, McDonald CC, Graham JB. Permanent cell line expressing human factor VIII - related antigen established by hybridization. Proc Natl Acad Sci USA 1983; 80: 3734-3737.
20. Bell WR, Royall RM. Heparin-associated thrombocytopenia: a comparison of three heparin preparations. N Engl J Med 1980; 303: 902-907
21. Le Tonquèze M et al. The relationship of anti-endothelial cell antibodies to anti-phospholipid antibodies in patients with giant cell artentis and/or polymyalgia rheumatica. Autoimmunity 1995; 20: 59-66.
22. Dueymes M et al. Role of β2-glycoprotein I in the anticardiolipin antibody affinity for phospholipid in autoimmune disease. Lupus 1995; 4: 477-481.
23. Dueymes M et al. Relationship of interleukin-4 to isotypic distribution of anti-double stranded DNA antibodies in systemic lupus erythematosus. Int Arch Allergy Immunol 1993; 101: 408-415.
24. Poulsen JH. Urine and tissue glycosaminoglycans and their interrelations. Dan Med Bull 1986; 33: 75-96.
25. Hylkema MN et al. A new ELISA for the detection of anti-heparan sulfate reactivity using photobiotinglated antigen. J Immunol Methods 1994; 176: 33-43.
26. Rumore PM, Steinman CR. Endogeneous circulating DNA in systemic lupus erythematosus. J Clin Invest 1990; 86: 69-74.
27. Bush C, Ljungman D, Heldin CM, Wasteson A, O'Brink B. Surface properties of endothelial cells. Haemostasis 1979; 8: 142-147.
28. Underhill CB. Naturally occurring antibodies which bind hyaluronate. Biochem Biophys Res Commun 1982; 108: 1488-1494.
29. Ronda N et al. Analysis of natural and disease-associated autoantibody repertoire : antiendothelial cell IgG autoantibody activity in the serum of healthy individuals and patients with systemic lupus erythematosus. Int Immunol 1994; 6: 1651-1660.
30. Amout J. The pathogenesis of the antiphospholipid syndrome: a hypothesis based on parallelisms with heparin induced thrombocytopenia Thromb Haemost 1996; 75: 536-541.
31. Le Tonquèze M et al. Establishment and characterization of permanent human endothelial cell clones. Lupus 1996; 5: 103-112.
32. Cines DB, Tomaski A, Tannenbaum S. Immune endothelial cell injury in heparin-associated thrombocytopenia. N Engl J Med 1987; 316: 581-589.
33. Amiral J et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 1992; 68: 95-96
34. Visentin GP, Ford SE, Scott P, Aster RH. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet 4 complexed with heparin or bound to endothelial cells. J Clin Invest 1994; 93: 81-88.
35. O'Brien JR, Etherington MD, Pashley M. Intra-platelet factor 4 (PF4) and the heparin mobilizable pool of PF4 in health and atherosclerosis. Thromb Haemost 1984; 51: 354-357.
36. Busch C, Dawes J, Pepper DS, Wasteson A. Binding of platelet factor 4 to cultured human umbilical vein endothelial cells. Thromb Res 1980; 19: 129-137.
37. Zucker MB, Katz IR. Platelet factor 4 : production, structure and physiologic and immunologic action. Proc Soc Exp Biol Med 1991; 198: 693-702.
38. Shibata S, Harpel P, Bona C, Fillit H. Monoclonal antibodies to heparan sulfate inhibit the formation of thrombin-antithrombin III complexes. Clin Immunol Immunopathol 1993; 67: 264-272.